Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Companies with NDRs 5/21
-
SelectQuote Inc. (SLQT) Prices 28.5M Share IPO at $20/Sh
-
European stocks hit by U.S.-China tensions, recovery doubt
-
SelectQuote Announces Pricing of Initial Public Offering
-
Trulieve Cannabis Corp (TRUL:CN) (TCNNF) PT Raised to $50 at Cantor Fitzgerald
-
Great Panther Announces Closing of US$16.1 Million Bought Deal Financing
-
Companies with NDRs 5/20
-
Pre-Open Stock Movers 05/19: (ABUS) (DVAX) (AAP) Higher; (BLPH) (GMDA) (GOOS) Lower (more...)
-
Companies with NDRs 5/19
-
After-Hours Stock Movers 05/18: (ABUS) (DAC) (BIDU) Higher; (BLPH) (GMDA) (GOSS) Lower (more...)
-
Cantor Fitzgerald Starts Rapt Therapeutics (RAPT) at Overweight
-
Johnson & Johnson to Provide Webcast Fireside Chat on Clinical Data to be Presented at the American Society of Clinical Oncology and the Janssen Oncology Strategy and Portfolio
-
cbdMD Inc. (YCBD) PT Raised to $1.80 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Coeur d'Alene Mines (CDE) at Buy (Earlier)
-
Companies with NDRs 5/15
-
TG Therapeutics (TGTX) Prices 8.5M Share Upsized Common Offering at $18/Sh
-
TG Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
-
TG Therapeutics (TGTX) Announces Proposed 6M Share Public Offering of Common Stock
-
TG Therapeutics Announces Proposed Public Offering of Common Stock
-
Buy Arvinas (ARVN) on Weakness - Cantor Fitzgerald
-
Margaret Lake Provides Corporate Updates
-
Great Panther Announces Upsizing of Bought Deal Financing to US$14 Million
-
Companies with NDRs 5/14
-
Orchid Island Capital Announces May 2020 Monthly Dividend and April 30, 2020 RMBS Portfolio Characteristics
-
Great Panther Announces US$10 Million Bought Deal Financing
-
Northern Dynasty Announces Closing Of C$10.1 Million Underwritten Offering
-
FortressIQ Announces $30 Million in Series B Funding, building AI to Decode Work
-
Companies with NDRs 5/13
-
Companies with NDRs 5/12
-
CymaBay Therapeutic (CBAY) PT Raised to $15 at Cantor Fitzgerald
-
Cantor Fitzgerald Starts Premier, Inc. (PINC) at Overweight
-
Companies with NDRs 5/11
-
Companies with NDRs 5/8
-
Fennec Announces Exercise and Closing of Underwriters’ Option to Purchase Additional Shares
-
UPDATE: Cantor Fitzgerald Upgrades Computer Programs and Systems (CPSI) to Overweight
-
vTv Therapeutics Announces 2020 First Quarter Financial Results and Update
-
Cantor Fitzgerald Downgrades ANI Pharmaceuticals (ANIP) to Neutral
-
NexPoint Makes Three New Sales and Marketing Appointments to Support Investment Platform Growth
-
COLLECTIVE GROWTH CORPORATION ANNOUNCES CLOSING OF $150 MILLION INITIAL PUBLIC OFFERING
-
COLLECTIVE GROWTH CORPORATION ANNOUNCES CLOSING OF $150 MILLION INITIAL PUBLIC OFFERING
-
Fennec Announces Closing of Public Offering
-
UPDATE: Collective Growth Corp. (CGRO) Prices 15M Unit IPO at $10/Unit
-
COLLECTIVE GROWTH CORPORATION ANNOUNCES PRICING OF $150 MILLION INITIAL PUBLIC OFFERING
-
COLLECTIVE GROWTH CORPORATION ANNOUNCES PRICING OF $150 MILLION INITIAL PUBLIC OFFERING
-
Orchid Island Capital Announces First Quarter 2020 Results
-
Fennec Pharmaceuticals (FENC) Prices 4.8M Common Stock Offering at $6.25/Share
-
Fennec Announces Pricing of Public Offering
-
Fennec Pharmaceuticals (FENC) Announces Proposed Public Offering of Common Shares
-
Fennec Announces Proposed Public Offering of Common Shares
-
Humana (HUM) PT Raised to $405 at Cantor Fitzgerald

